AIM: Some probiotics improve digestive comfort of people with Irritable Bowel Syndrome, but this needs confirmation in a healthy population. The objective of this pilot study was to investigate the effect of consuming fermented milk containing the probiotics Bifidobacterium lactis DN-173010 and yoghourt strains (test product) on digestive comfort and symptoms amongst adults without diagnosed gastrointestinal disorders. METHODS: The study was designed to approximate a real-life situation, by using a branded product in the intervention groups. In an open-label, randomized, controlled trial, 371 adults reporting digestive discomfort were randomized into three groups who had a daily consumption of either one or two pots of test product over 2 weeks, or to follow their usual diet. Digestive comfort and bother from digestive symptoms were assessed by questionnaire at baseline and follow-up (per protocol population n = 360). Self-reported change in digestive comfort and computed change between baseline and follow-up for each of 20 items were compared between groups (Cochran-Mantel-Haenszel test). RESULTS: A higher percentage of participants consuming the test product reported improved digestive comfort (1-pot group 82.5%; 2-pot group 84.3%), than controls (2.9%). Their self-reported change scores differed significantly (P < 0.001). For both test product groups, almost all symptom scores improved significantly more than controls (P < 0.001). There were no significant differences between 1-pot and 2-pot groups. CONCLUSIONS: This pilot study shows that daily consumption of a probiotic food in real-life conditions may be useful in improving digestive comfort and symptom experience of adults from general population. Further double-blind randomized controlled studies are required to confirm these health benefits.
RCT Entities:
AIM: Some probiotics improve digestive comfort of people with Irritable Bowel Syndrome, but this needs confirmation in a healthy population. The objective of this pilot study was to investigate the effect of consuming fermented milk containing the probiotics Bifidobacterium lactis DN-173010 and yoghourt strains (test product) on digestive comfort and symptoms amongst adults without diagnosed gastrointestinal disorders. METHODS: The study was designed to approximate a real-life situation, by using a branded product in the intervention groups. In an open-label, randomized, controlled trial, 371 adults reporting digestive discomfort were randomized into three groups who had a daily consumption of either one or two pots of test product over 2 weeks, or to follow their usual diet. Digestive comfort and bother from digestive symptoms were assessed by questionnaire at baseline and follow-up (per protocol population n = 360). Self-reported change in digestive comfort and computed change between baseline and follow-up for each of 20 items were compared between groups (Cochran-Mantel-Haenszel test). RESULTS: A higher percentage of participants consuming the test product reported improved digestive comfort (1-pot group 82.5%; 2-pot group 84.3%), than controls (2.9%). Their self-reported change scores differed significantly (P < 0.001). For both test product groups, almost all symptom scores improved significantly more than controls (P < 0.001). There were no significant differences between 1-pot and 2-pot groups. CONCLUSIONS: This pilot study shows that daily consumption of a probiotic food in real-life conditions may be useful in improving digestive comfort and symptom experience of adults from general population. Further double-blind randomized controlled studies are required to confirm these health benefits.
Authors: Joseph R Loquasto; Rodolphe Barrangou; Edward G Dudley; Buffy Stahl; Chun Chen; Robert F Roberts Journal: Appl Environ Microbiol Date: 2013-08-30 Impact factor: 4.792
Authors: Jacqui Eales; Peter Gibson; Peter Whorwell; John Kellow; Ann Yellowlees; Richard H J Perry; Mary Edwards; Sarah King; Hannah Wood; Julie Glanville Journal: Therap Adv Gastroenterol Date: 2016-10-10 Impact factor: 4.409
Authors: Boris Le Nevé; Adrian Martinez de la Torre; Julien Tap; Muriel Derrien; Aurélie Cotillard; Elizabeth Barba; Marianela Mego; Adoración Nieto Ruiz; Laura Hernandez-Palet; Quentin Dornic; Jean-Michel Faurie; John Butler; Xavi Merino; Beatriz Lobo; Ferran Pinsach Batet; Anna Accarino; Marta Pozuelo; Chaysavanh Manichanh; Fernando Azpiroz Journal: Nutrients Date: 2020-01-25 Impact factor: 5.717
Authors: Rebeca Martín; Laure Laval; Florian Chain; Sylvie Miquel; Jane Natividad; Claire Cherbuy; Harry Sokol; Elena F Verdu; Johan van Hylckama Vlieg; Luis G Bermudez-Humaran; Tamara Smokvina; Philippe Langella Journal: Front Microbiol Date: 2016-05-06 Impact factor: 5.640